| Drowsiness detection using heart rate variability J Vicente, P Laguna, A Bartra, R Bailón Medical & biological engineering & computing 54 (6), 927-937, 2016 | 296 | 2016 |
| An evaluation of 30 clinical drugs against the comprehensive in vitro proarrhythmia assay (CiPA) proposed ion channel panel WJ Crumb Jr, J Vicente, L Johannesen, DG Strauss Journal of pharmacological and toxicological methods 81, 251-262, 2016 | 259 | 2016 |
| Comprehensive translational assessment of human-induced pluripotent stem cell derived cardiomyocytes for evaluating drug-induced arrhythmias K Blinova, J Stohlman, J Vicente, D Chan, L Johannesen, ... Toxicological Sciences 155 (1), 234-247, 2016 | 243 | 2016 |
| Differentiating Drug‐Induced Multichannel Block on the Electrocardiogram: Randomized Study of Dofetilide, Quinidine, Ranolazine, and Verapamil L Johannesen, J Vicente, JW Mason, C Sanabria, K Waite‐Labott, ... Clinical Pharmacology & Therapeutics 96 (5), 549-558, 2014 | 236 | 2014 |
| Late sodium current block for drug‐induced long QT syndrome: Results from a prospective clinical trial L Johannesen, J Vicente, JW Mason, C Erato, C Sanabria, K Waite‐Labott, ... Clinical Pharmacology & Therapeutics 99 (2), 214-223, 2016 | 135 | 2016 |
| Comprehensive T wave Morphology Assessment in a Randomized Clinical Study of Dofetilide, Quinidine, Ranolazine, and Verapamil J Vicente, L Johannesen, JW Mason, WJ Crumb, E Pueyo, N Stockbridge, ... Journal of the American Heart Association 4 (4), e001615, 2015 | 135 | 2015 |
| Mechanistic Model‐Informed Proarrhythmic Risk Assessment of Drugs: Review of the “CiPA” Initiative and Design of a Prospective Clinical Validation Study J Vicente, R Zusterzeel, L Johannesen, J Mason, P Sager, V Patel, ... Clinical Pharmacology & Therapeutics 103 (1), 54-66, 2018 | 118 | 2018 |
| Common Genetic Variant Risk Score is Associated with Drug-Induced QT Prolongation and Torsade de Pointes Risk: A Pilot Study DG Strauss, J Vicente, L Johannesen, K Blinova, JW Mason, P Weeke, ... Circulation, 2017 | 116 | 2017 |
| Detection of driver's drowsiness by means of HRV analysis J Vicente, P Laguna, A Bartra, R Bailón 2011 Computing in Cardiology, 89-92, 2011 | 100 | 2011 |
| Improving the Assessment of Heart Toxicity for All New Drugs through Translational Regulatory Science L Johannesen, J Vicente, RA Gray, L Galeotti, Z Loring, CE Garnett, ... Clinical Pharmacology & Therapeutics 95 (5), 501-508, 2014 | 93 | 2014 |
| Mechanisms of sex and age differences in ventricular repolarization in humans J Vicente, L Johannesen, L Galeotti, DG Strauss American heart journal 168 (5), 749-756. e3, 2014 | 85 | 2014 |
| Comprehensive in vitro proarrhythmia assay (cipa) update from a cardiac safety research consortium/health and environmental sciences institute/fda meeting DG Strauss, G Gintant, Z Li, W Wu, K Blinova, J Vicente, JR Turner, ... Therapeutic innovation & regulatory science 53 (4), 519-525, 2019 | 82 | 2019 |
| Assessment of Multi‐Ion Channel Block in a Phase I Randomized Study Design: Results of the Ci PA Phase I ECG Biomarker Validation Study J Vicente, R Zusterzeel, L Johannesen, R Ochoa‐Jimenez, JW Mason, ... Clinical Pharmacology & Therapeutics 105 (4), 943-953, 2019 | 69 | 2019 |
| Electrocardiographic Biomarkers for Detection of Drug-Induced Late Sodium Current Block J Vicente, L Johannesen, M Hosseini, JW Mason, PT Sager, E Pueyo, ... PLOS ONE 11 (12), e0163619, 2016 | 43 | 2016 |
| Clinical trial in a dish: personalized stem cell derived cardiomyocyte assay compared to clinical trial results for two QT prolonging drugs K Blinova, D Schocken, D Patel, C Daluwatte, J Vicente, JC Wu, ... Clinical and Translational Science, 2019 | 41 | 2019 |
| Automated Algorithm for J-Tpeak and Tpeak-Tend Assessment of Drug-Induced Proarrhythmia Risk L Johannesen, J Vicente, M Hosseini, DG Strauss PLOS ONE 11 (12), e0166925, 2016 | 41 | 2016 |
| Assessing ECG signal quality indices to discriminate ECGs with artefacts from pathologically different arrhythmic ECGs C Daluwatte, L Johannesen, L Galeotti, J Vicente, DG Strauss, CG Scully Physiological Measurement 37 (8), 1370, 2016 | 33 | 2016 |
| Heart rate dependency of JT interval sections K Hnatkova, L Johannesen, J Vicente, M Malik Journal of Electrocardiology 50 (6), 814-824, 2017 | 28 | 2017 |
| Evolving regulatory paradigm for proarrhythmic risk assessment for new drugs J Vicente, N Stockbridge, DG Strauss Journal of Electrocardiology 49 (6), 837-842, 2016 | 28 | 2016 |
| Comparative analysis of media effects on human induced pluripotent stem cell-derived cardiomyocytes in proarrhythmia risk assessment D Schocken, J Stohlman, J Vicente, D Chan, D Patel, MK Matta, V Patel, ... Journal of pharmacological and toxicological methods 90, 39-47, 2018 | 27 | 2018 |
David G StraussFDAVerified email at fda.hhs.gov
